[Effect of pyrimidine derivatives on the adenylate cyclase system of regulation of immunocompetent cells in vitro].
Slabnov
Iu D
IuD
Cherepnev
G V
GV
Karimova
F G
FG
Garaev
R S
RS
D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000097:blood; D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects* / Q000201:enzymology / Q000276:immunology; D004338:Drug Combinations; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D008198:Lymph Nodes / Q000166:cytology / Q000187:drug effects / Q000201:enzymology / Q000276:immunology; D009928:Organ Specificity; D011743:Pyrimidines / Q000494:pharmacology*; D013045:Species Specificity; D013450:Sulfones / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000187:drug effects* / Q000201:enzymology / Q000276:immunology; D013950:Thymus Gland / Q000166:cytology / Q000187:drug effects / Q000201:enzymology / Q000276:immunology; D014498:Uracil / Q000031:analogs & derivatives* / Q000494:pharmacology
D000067956:Adenylyl Cyclase Inhibitors; D004338:Drug Combinations; D004791:Enzyme Inhibitors; D011743:Pyrimidines; D013450:Sulfones; C069705:xymedon; C023367:diucifon; D014498:Uracil; D000262:Adenylyl Cyclases